Aclaris Therapeutics ACRS Payment Of Deferred Transactions Consideration To Acquire Intangible Assets
Payment Of Deferred Transactions Consideration To Acquire Intangible Assets at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept acrs:PaymentOfDeferredTransactionsConsiderationToAcquireIntangibleAssets.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's payment of deferred transactions consideration to acquire intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's payment of deferred transactions consideration to acquire intangible assets?
- Aclaris Therapeutics (ACRS) reported payment of deferred transactions consideration to acquire intangible assets of $833K in Q1 2025.
- What does payment of deferred transactions consideration to acquire intangible assets mean?
- This represents cash outflows made to settle deferred payment obligations arising from past acquisitions or asset purchases. It reflects the realization of liabilities incurred during inorganic expansion efforts. Tracking these payments is essential for understanding the actual cash cost of historical business combinations.